analyst omits consideration for effect of Fed tapering announcement. many of these stocks have significant levels of leveraging
Reopening stocks either near bottom or have just rode out Omicron correction: DBS
UNLESS the Omicron coronavirus variant turns out to be highly virulent and existing vaccines become
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
2
举报
登录后可参与评论
暂无评论